PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 43 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
| Q1 2016 | $71,000 | -79.4% | 68,884 | -41.2% | 0.00% | – |
| Q4 2015 | $344,000 | -33.8% | 117,070 | -29.1% | 0.00% | – |
| Q3 2015 | $520,000 | -53.5% | 165,090 | -12.8% | 0.00% | -100.0% |
| Q2 2015 | $1,119,000 | +8.9% | 189,338 | +96.7% | 0.00% | 0.0% |
| Q1 2015 | $1,028,000 | +0.4% | 96,267 | -11.8% | 0.00% | 0.0% |
| Q4 2014 | $1,024,000 | +186.8% | 109,189 | +134.0% | 0.00% | – |
| Q3 2014 | $357,000 | +792.5% | 46,652 | +922.4% | 0.00% | – |
| Q2 2014 | $40,000 | -7.0% | 4,563 | -44.2% | 0.00% | – |
| Q1 2014 | $43,000 | +377.8% | 8,180 | +123.8% | 0.00% | – |
| Q4 2013 | $9,000 | -85.0% | 3,655 | -83.6% | 0.00% | – |
| Q3 2013 | $60,000 | – | 22,339 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sageview Capital | 2,223,339 | $5,603,000 | 1.59% |
| Orbimed Advisors | 2,320,800 | $5,848,000 | 0.09% |
| F&C Asset Management plc | 1,854,808 | $4,665,000 | 0.06% |
| SPHERA FUNDS MANAGEMENT LTD. | 56,500 | $142,000 | 0.04% |
| Yakira Capital Management, Inc. | 11,957 | $30,000 | 0.03% |
| Spectrum Management Group, LLC | 10,000 | $25,000 | 0.02% |
| Weiss Multi-Strategy Advisers LLC | 41,152 | $104,000 | 0.00% |
| WOLVERINE ASSET MANAGEMENT LLC | 30,000 | $75,000 | 0.00% |
| PUTNAM INVESTMENTS LLC | 129,762 | $327,000 | 0.00% |
| Partnervest Advisory Services LLC | 220 | $1,000 | 0.00% |